Similar articles

• [Current status of immunosuppression].

  Kaspar F. Kaspar F. Dtsch Med J. 1968 Apr 5;19(7):211-3. Dtsch Med J. 1968. PMID: 4180292 German. No abstract available.
• [Biologic fundamentals and advances in kidney transplantation. IV. Immunosuppression with antilymphocytic serum and specific tolerances].

  Lawson RK, Kirchheim D. Lawson RK, et al. Urologe. 1967 Nov-Dec;6(6):359-67. Urologe. 1967. PMID: 4873352 German. No abstract available.
• Studies on the mechanism of rejection of tolerated skin homografts and abrogation of immunological tolerance by hyperimmune serum.

  Hasek M, Skamene E, Karakoz I, Chutná J, Nouza K, Bubeník J, Sovová V, Nĕmec M, Jonák J. Hasek M, et al. Folia Biol (Praha). 1968;14(6):411-24. Folia Biol (Praha). 1968. PMID: 4236901 No abstract available.
• An introduction to immunosuppressants.

  Aisenberg AC. Aisenberg AC. Adv Pharmacol Chemother. 1970;8:31-55. doi: 10.1016/s1054-3589(08)60593-1. Adv Pharmacol Chemother. 1970. PMID: 4400437 Review. No abstract available.
• Mode of action of antilymphocyte serum.

  DeMeester TR. DeMeester TR. Surg Gynecol Obstet. 1969 Oct;129(4):717-22. Surg Gynecol Obstet. 1969. PMID: 4898242 Review. No abstract available.